...China for years, but with their businesses now suffering, even major pharmaceutical companies like AstraZeneca, Bayer, Baxter and Pfizer have announced deals to outsource manufacturing to China. We all know the result: fake heparin ingredients. And not because...

...The first of those companies, he said, should be drug giant Pfizer (PFE Quote - Cramer on PFE - Stock Picks). Cramer said Pfizer should consider buying Botox maker Allergan (AGN Quote - Cramer on AGN - Stock Picks). He said Allergan, which up until today competed...

...care you’d be hard pressed to remember that the US is in a recession. And J&J isn’t the only drug maker with cash on hand. Pfizer [PFE Loading... () ], Wyeth [WYE Loading... () ], and others are sitting on mountains of money leaving some to speculate...

...in 2000, when Warner-Lambert paid American Home Products $1.8bn for breaking their proposed merger in favour of a deal with Pfizer. Pfizer challenged the break fee on the grounds that it was unreasonably high and claimed that Warner had breached its duty to...

...210 or +1 949 725 2946 or alternatively please visit www.excointouch.com For further information on Pfizer, please visit www.pfizer.co.uk -ENDS- For further press information please contact: Eleanor CallanMonk, The Scott Partnership, 1 Whiteside, Station...

...Agrosciences in plant agriculture and Sigma-Aldrich Corporation in research reagents. We also have agreements with Genentech and Pfizer in cell-line engineering. We plan to establish strategic partnerships around our therapeutic programs at points of value...

...Mukherjee as Senior Vice-President, Clinical Development. Prior to the current assignment, Dr Mukherjee had served Ranbaxy and Pfizer in senior positions. The Hyderabad-based company has also strengthened its international clinical research business development...

... You expect a group like PhRMA to take a defensive position. That's its job. But I was surprised when this press release from Pfizer popped up in the inbox this morning (see link below) only hours after the JAMA study came out. The communication touts the...

...policies. As the WSJ reported, back in 2005, the agency decided that pills for Alzheimer’s were too costly, angering patients and Pfizer. Last May a UK court ordered the agency to reveal how it crunched the numbers. Michael Rawlins, the doctor who heads NICE,...

...acquisition prohibitively expensive, would be triggered if an investor acquires 15 percent or more of Icagen shares. Drug giant Pfizer, which already owns 18 percent of Icagen, would trigger the rights plan if it acquires a 20 percent stake. The rights plan...